SCHEMBL10110930

SCHEMBL10110930

Cc1ccc(C)c(CCCCCCC(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ F13A1 P00488 3/20 0.56
▸ TSHR P16473 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ TAAR1 Q96RJ0 1/20 0.49
▸ MAPT P10636 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ LTB4R Q15722 2/20 0.47
▸ PTGER1 P34995 1/20 0.45
▸ PTGER4 P35408 1/20 0.45
▸ PTGER3 P43115 1/20 0.45
▸ PTGER2 P43116 1/20 0.45
▸ GAA P10253 1/20 0.44
▸ FFAR1 O14842 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207760 0.98 TSHR (0.57) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL1006607 0.93 TSHR (0.58) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL11286813 0.87 F13A1 (0.56) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL12718754 0.87 TAAR1 (0.53) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL28516930 0.87 F13A1 (0.56) F13A1TSHRMAPTRXFP1LTB4R
SCHEMBL3925297 0.87 F13A1 (0.56) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL29636581 0.86 NPSR1 (0.68) TSHRNPSR1MEN1KMT2ATAAR1
SCHEMBL3670598 0.86 NPSR1 (0.68) TSHRNPSR1MEN1KMT2ATAAR1
SCHEMBL6207355 0.85 F13A1 (0.53) F13A1TSHRNPSR1MEN1KMT2A
SCHEMBL13104300 0.84 F13A1 (0.53) F13A1TSHRMAPTRXFP1LTB4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9704612-B2 Composition of silver-conjugated compound composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-07-11 — — US disclosed
US-9536633-B2 Metallic composite and composition thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-01-03 — — US disclosed
US-9412487-B2 Silver-(conjugated compound) composite SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-08-09 — — US disclosed
US-20120168693-A1 SILVER-(CONJUGATED COMPOUND) COMPOSITE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-05 — — US disclosed
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF CDH1, EPCAM, CD4 F13A1 1528/4885TSHR 3714/4885NPSR1 3318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback